Keep tabs on your favorite ETFs with a personalized weekly tracker. Create a Watchlist now →

Advertisement
Advertisement
Moving Markets

Marijuana ETFs soar on Biden's reforms

This recent regulatory update is a game-changer and a massive catalyst for the marijuana industry.

Marijuana ETFs soar on Biden's reforms

Keep up with what matters in ETFs

Get timely ETF insights, market trends, and top ideas straight to your inbox.

Your newsletter subscriptions with us are subject to ETF Central's Privacy Policy and Terms and Conditions.

The marijuana industry is finally experiencing a reprieve after years of underperformance following the 2018 "Weed Stock Mania." On October 6th, 2022, President Biden announced major reforms, which included:

  • A pardon of all prior Federal offenses of simple possession of marijuana.
  • Directing the Attorney General to develop an administrative process for issuing pardons to eligible individuals.
  • Urging all state Governors to emulate the Federal government with regard to state offenses.
  • Asking the Secretary of Health and Human Services and the Attorney General to immediately review how marijuana is scheduled under federal law.

Marijuana stocks and ETFs soared on the news. For example, the AdvisorShares Pure U.S. Cannabis ETF (MSOS) jumped nearly 40% intra-day as its underlying holdings surged. Other marijuana ETFs also saw strong inflows, signaling high amounts of investor interest. 

ETF Central Weekly Newsletter

Like what you're reading?

Stay in the loop — get the latest ETF insights: trends, analysis, and expert picks.

After signing up, you will receive occasional emails from ETF Central and its partners. See our Terms of use.

What the reforms mean moving forward

Jason Wilson, Cannabis Banking Expert at ETFMG was of the opinion that the recent announcement was merely the beginning of a long-awaited and extensive cannabis reform process. Wilson told me:

"Although President Biden did not go as far as Germany recently has by announcing that they will table draft legalization legislation by the end of the year, the President’s acknowledgment that it is time to right the wrongs of the federal government’s failed approach to marijuana, combined with his instructions to the Secretary of Health and Human Sciences and the Attorney General to expeditiously review marijuana’s classification under federal laws, provide a strong and important political statement suggesting that long-awaited cannabis reform may arrive sooner than expected."

This is a highly bullish sentiment evidently shared and anticipated by the market for a long time ever since Biden's 2020 campaign promises. The surge in cannabis stocks was likely a result of the "surprise" from the sudden announcement of these reforms previously discounted as a more remote possibility. 

What Wilson found particularly important was Biden's instructions to the Secretary of Health and Human Services and the Attorney General to expeditiously review marijuana’s status under federal law. Wilson noted that this action effectively commenced the process to reschedule or de-schedule cannabis altogether under the Controlled Substances Act, where it is currently classified as Schedule I, the same classification as the most dangerous substances like heroin and LSD.

That being said, Wilson does not anticipate Biden's actions alone having a short-term material impact on the cannabis industry. "The path to rescheduling or de-scheduling cannabis by way of executive action will be a long and bureaucratic process that will take some time to work through, but Biden's actions did add momentum," he says. 

Investing in marijuana

Investors interested in the marijuana industry can use a variety of ETFs to gain exposure. It's worth carefully examining each fund's construction, methodology, and strategy. Some things to note when conducting your analysis include:

  • Is the ETF pure play (holding only marijuana companies), or does it also hold tobacco companies with incidental exposure?
  • Does the ETF physically hold the underlying securities, or does it use a derivative like a total return swap to gain synthetic exposure?
  • Is the ETF market capitalization-weighted or weighted according to another methodology (common ones include equal weight or weighted by pure-play exposure)?
  • What geographies do the holdings in the ETF come from? Is it U.S. only, North America only, or globally diversified?

Depending on your preferences for the above, the following ETFs might be suitable for expressing a long position in the marijuana industry:

Please note this article is for information purposes only and does not constitute investment advice.

Advertisement
Advertisement
Advertisement
ETF U
Become a better investor with NYSE: The Home of ETFs
Visit the ETF U homepage
ETF Guides
Advertisement

Recent educational content

PRIV ETF

What’sTheFund

What's the Fund | State Street SPDR IG Public & Private Credit ETF (Ticker: PRIV)

Matthew Bartolini, Global Head of Research Strategists, at State Street Investment Management, joins Ethan Hertzfeld on the New York Stock Exchange Floor to discuss PRIV, the State Street SPDR IG Public & Private Credit ETF.

NYSE logo
By NYSE · April 28, 2026
Tidal ETF Industry KPIs

ETF Trends

ETF Industry KPIs April 27, 2026

The ETF Industry saw 23 New Launches, 1 Ticker Change and 4 closures last week.

Tidal
By Tidal · April 28, 2026
Investors Can Fight Healthcare Inflation with Newly Launched ETFs

Asset TV

The ETF Show - Investors Can Fight Healthcare Inflation with Newly Launched ETFs

Adam Schenck, Principal and Managing Director of Fund Services at Milliman joined The ETF Show to discuss Milliman's first ETFs designed to hedge against rising healthcare inflation.

Asset TV
By Asset TV · April 22, 2026
Tidal ETF Industry KPIs

ETF Trends

ETF Industry KPIs April 20, 2026

The ETF Industry saw 14 New Launches, 1 Ticker Change and 16 closures last week.

Tidal
By Tidal · April 22, 2026

Browse all educational columns

Advertisement
Webcast on Demand

Calamos Investments Powers the Next Phase of the Autocallable Revolution

Join J.P. Morgan’s Bram Kaplan, Head of Americas Equity Derivatives Strategy and Matt Kaufman from Calamos Investments as they dive into the growing global opportunity in autocallable income—an increasingly dominant strategy within structured products, now available through ETFs.

Accepted for 1 CE Credit

Calamos Webcast